Janaki Parameswaran

Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck

Jong Woo Lee, Janaki Parameswaran, Teresa Sandoval-Schaefer et al. · Clinical Cancer Research · 2019 · 73 citations · Full text

Medicine, Oncology, Pharmacology +14

Abstract GS3-03: GS3-03 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study

Anne F. Schott, Sara A. Hurvitz, Erika Hamilton et al. · Cancer Research · 2023 · 34 citations

Medicine, Oncology, Pharmacology +17

Two Microrna Signatures for Malignancy and Immune Infiltration Predict Overall Survival in Advanced Epithelial Ovarian Cancer

Ilya Korsunsky, Janaki Parameswaran, Iuliana Shapira et al. · Journal of Investigative Medicine · 2017 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +17

394 Interleukin-8–neutralizing monoclonal antibody BMS-986253 plus nivolumab (NIVO) in biomarker-enriched, primarily anti–PD-(L)1–experienced patients with advanced cancer: initial phase 1 results

Diwakar Davar, Matteo Simonelli, Martin Gutierrez et al. · Regular and Young Investigator Award Abstracts · 2020 · 15 citations · Full text

Medicine, Immunology, Oncology +17